T: +44 (0)1623 751 500
E: info@advancissurgical.com

"Cell salvage is considered to be an increasingly important part of modern patient blood management."

 
What is Homosep

What is Hemosep?

We are delighted to release the next generation of Hemosep - our innovative cell salvage system.

The Hemosep cell salvage system is designed to recover blood loss during cardiac and other surgical specialities, providing a concentration of all cell species for transfusion back to the patient.

It offers exciting new opportunities for health services to improve patient outcomes and reduce costs. 

More info

 

Why is Hemosep different?

Hemosep is the result of a partnership of Advancis Surgical and Professor Terence Gourlay at the University of Strathclyde. Clinical trials have already been undertaken at University Hospital in Ankara, Turkey and Guy’s and St Thomas’ Hospital, London. 

Professor Terence Gourlay, says: “The introduction of Hemosep to the medical device field will make a significant difference to people’s lives and greatly reduce the cost and risks associated with blood transfusions. The technology has distinct advantages over traditional techniques which are not only costly but technically challenging and involve the use of a complex centrifuge and pumping apparatus by specialist technicians.”

Professor Serdar Gunaydin, University of Kirkkale, Turkey,  says: “The Hemosep technology has produced impressive results, it is the easiest method we have ever used. There is no interference with the on-going operation and product is ready following a very short processing time. We believe this new technology will be one of the essential components of routine heart surgery in the near future.”

Stephen Cotton, Brightwake’s Managing Director, said: “We’re delighted to be able to make this announcement, which comes after considerable shared effort to develop this exciting product. We hope that this success will be the first of many through our collaboration with the University of Strathclyde.”

More info

 

 
What is Homosep
Blue bar with white text
Please note

"Hemosep could reduce risks such as potential blood mismatch and transmission of viral infections."

3 box benefits
Advancis Surgical clinical benefits

Clinical Benefits

More information on Advancis Surgical cost benefits

Clinical Benefits

Hemosep offers a significant number of clinical benefits when utilised for intraoperative cell salvage

More info
Advancis Surgical cost benefits

Cost Benefits

More information on Advancis Surgical cost benefits

Cost Benefits

Hemosep can introduce significant cost savings to the clinical teams that use it by reducing the need to add platelets to a patient and therefore also reducing the risk of postoperative bleeding.

More info
SYSTEM Register your interest

Register Your Interest

Register your email for your free copy of the Hemosep brochure!


By submitting this form I understand that Advancis will
store my data in accordance with their Privacy policy.

For any further queries please contact us.